Alimera Sciences To Present At Cantor Fitzgerald Inaugural Healthcare Conference

ATLANTA, June 29, 2015 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Rick Eiswirth, Chief Operating Officer and Chief Financial Officer, will present at the 2015 Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 at 8:00 a.m. ET at Le Parker Meridien Hotel in New York.

The presentation will be webcast live and will be available for access, along with the slides that will be used for the presentation, on the Investor Relations section of the corporate website at www.alimerasciences.com. For those who are not available to listen to the live broadcast, the webcast will be archived for 90 days.

About Alimera Sciences, Inc.

Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from London by its subsidiary, Alimera Sciences Limited, which has offices in Aldershot, U.K., Berlin, Germany and Lisbon, Portugal.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alimera-sciences-to-present-at-cantor-fitzgerald-inaugural-healthcare-conference-300106163.html

SOURCE Alimera Sciences, Inc.